{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "ERK",
      "entity_type" : "family"
    },
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uniprot:P15056",
      "entity_text" : "BRAF",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "uniprot:P04049",
      "entity_text" : "CRAF",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "In the current study, we observed that Vemurafenib could promote BRAF / CRAF dimerization causing paradoxical ERK activation in Vemurafenib resistant DTC cells.",
  "reading_complete" : "2020-08-02T16:51:18Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:49:24Z",
  "trigger" : "causing",
  "evidence" : [ "BRAF/CRAF dimerization causing paradoxical ERK" ],
  "pmc_id" : "5381260",
  "score" : 0
}